[1] R.J. Davis, Signal transduction by the JNK group of MAP kinases, Cell. 103 (2000) 239–252. https://doi.org/10.1016/S0092-8674(00)00116-1.
[2] C.R. Weston, R.J. Davis, The JNK signal transduction pathway, Curr. Opin. Genet. Dev. 12 (2002) 14–21. https://doi.org/10.1016/S0959-437X(01)00258-1.
[3] J. Cui, M. Zhang, Y.Q. Zhang, Z.H. Xu, JNK pathway: Diseases and therapeutic potential, Acta Pharmacol. Sin. 28 (2007) 601–608. https://doi.org/10.1111/j.1745-7254.2007.00579.x.
[4] A. Zeke, M. Misheva, A. Reményi, M.A. Bogoyevitch, JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships, Microbiol. Mol. Biol. Rev. 80 (2016) 793–835. https://doi.org/10.1128/mmbr.00043-14.
[5] E.A. Willoughby, G.R. Perkins, M.K. Collins, A.J. Whitmarsh, The JNK-interacting protein-1 scaffold protein targets MAPK phosphatase-7 to dephosphorylate JNK, J. Biol. Chem. 278 (2003) 10731–10736. https://doi.org/10.1074/jbc.M207324200.
[6] B.J. Pulverer, J.M. Kyriakis, J. Avruch, E. Nikolakaki, J.R. Woodgett, Phosphorylation of c-jun mediated by MAP kinases, Nature. 353 (1991) 670–674. https://doi.org/10.1038/353670a0.
[7] D.N. Dhanasekaran, E.P. Reddy, JNK signaling in apoptosis, Oncogene. 27 (2008) 6245–6251. https://doi.org/10.1038/onc.2008.301.
[8] Y. Xia, C. Makris, B. Su, E. Li, J. Yang, G.R. Nemerow, M. Karin, MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5243–5248. https://doi.org/10.1073/pnas.97.10.5243.
[9] K.J. Barnham, C.L. Masters, A.I. Bush, Neurodegenerative diseases and oxidatives stress, Nat. Rev. Drug Discov. 3 (2004) 205–214. https://doi.org/10.1038/nrd1330.
[10] V. Sosa, T. Moliné, R. Somoza, R. Paciucci, H. Kondoh, M.E. LLeonart, Oxidative stress and cancer: An overview, Ageing Res. Rev. 12 (2013) 376–390. https://doi.org/10.1016/j.arr.2012.10.004.
[11] J.F. Turrens, A. Boveris, Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria., Biochem. J. 191 (1980) 421–427. https://doi.org/10.1042/bj1910421.
[12] K. Sinha, J. Das, P.B. Pal, P.C. Sil, Oxidative stress: The mitochondria-dependent and mitochondria-independent pathways of apoptosis, Arch. Toxicol. 87 (2013) 1157–1180. https://doi.org/10.1007/s00204-013-1034-4.
[13] M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, H. Ichijo, Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1, EMBO J. 17 (1998) 2596–2606.
[14] O. Singh, A. Shillings, P. Craggs, I. Wall, P. Rowland, T. Skarzynski, C.I. Hobbs, P. Hardwick, R. Tanner, M. Blunt, D.R. Witty, K.J. Smith, Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design, Protein Sci. 22 (2013) 1071–1077. https://doi.org/10.1002/pro.2298.
[15] J. Yasuda, A.J. Whitmarsh, J. Cavanagh, M. Sharma, R.J. Davis, The JIP Group of Mitogen-Activated Protein Kinase Scaffold Proteins, Mol. Cell. Biol. 19 (1999) 7245–7254. https://doi.org/10.1128/mcb.19.10.7245.
[16] B. Dérijard, M. Hibi, I.H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, R.J. Davis, JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain, Cell. 76 (1994) 1025–1037. https://doi.org/10.1016/0092-8674(94)90380-8.
[17] S. Gupta, D. Campbell, B. Dérijard, R.J. Davis, Transcription factor ATF2 regulation by the JNK signal transduction pathway, Science (80-. ). 267 (1995) 389–393. https://doi.org/10.1126/science.7824938.
[18] C.R. Weston, R.J. Davis, The JNK signal transduction pathway, Curr. Opin. Cell Biol. 19 (2007) 142–149. https://doi.org/10.1016/j.ceb.2007.02.001.
[19] R. Van Der Lee, M. Buljan, B. Lang, R.J. Weatheritt, G.W. Daughdrill, A.K. Dunker, M. Fuxreiter, J. Gough, J. Gsponer, D.T. Jones, P.M. Kim, R.W. Kriwacki, C.J. Oldfield, R. V. Pappu, P. Tompa, V.N. Uversky, P.E. Wright, M.M. Babu, Classification of intrinsically disordered regions and proteins, Chem. Rev. 114 (2014) 6589–6631. https://doi.org/10.1021/cr400525m.
[20] T. Chouard, Structural biology: Breaking the protein rules, Nature. 471 (2011) 151–153. https://doi.org/10.1038/471151a.
[21] P.E. Wright, H.J. Dyson, Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm, J. Mol. Biol. 293 (1999) 321–331. https://doi.org/10.1006/jmbi.1999.3110.
[22] P.E. Wright, H.J. Dyson, Intrinsically disordered proteins in cellular signalling and regulation, Nat. Rev. Mol. Cell Biol. 16 (2015) 18–29. https://doi.org/10.1038/nrm3920.
[23] A. Katuwawala, Z. Peng, J. Yang, L. Kurgan, Computational Prediction of MoRFs, Short Disorder-to-order Transitioning Protein Binding Regions, Comput. Struct. Biotechnol. J. 17 (2019) 454–462. https://doi.org/10.1016/j.csbj.2019.03.013.
[24] V.N. Uversky, C.J. Oldfield, A.K. Dunker, Intrinsically Disordered Proteins in Human Diseases: Introducing the D 2 Concept , Annu. Rev. Biophys. 37 (2008) 215–246. https://doi.org/10.1146/annurev.biophys.37.032807.125924.
[25] A. et al. Bateman, UniProt: The universal protein knowledgebase, Nucleic Acids Res. 45 (2017) D158–D169. https://doi.org/10.1093/nar/gkw1099.
[26] R. P, O. Z, L. X, G. EC, B. CJ, D. AK, Sequence Complexity of Disordered Protein, Proteins. 42 (2001). https://doi.org/10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3.
[27] Peng Kang, R. Predrag, V. Slobodan, D.A. Keith, O. Zoran, Length-dependent Prediction of Protein Intrinsic Disorder, BMC Bioinformatics. (2006). https://pubmed.ncbi.nlm.nih.gov/16618368/ (accessed June 22, 2020).
[28] K. Peng, S. Vucetic, P. Radivojac, C.J. Brown, A.K. Dunker, Z. Obradovic, Optimizing long intrinsic disorder predictors with protein evolutionary information, J. Bioinform. Comput. Biol. 3 (2005) 35–60. https://doi.org/10.1142/S0219720005000886.
[29] S.I. Dosztányi Zsuzsanna, Csizmok Veronika, Tompa Peter, IUPred: Web Server for the Prediction of Intrinsically Unstructured Regions of Proteins Based on Estimated Energy Content, Bioinformatics. (2005). https://pubmed.ncbi.nlm.nih.gov/15955779/ (accessed June 22, 2020).
[30] B. Xue, R.L. Dunbrack, R.W. Williams, A.K. Dunker, V.N. Uversky, PONDR-FIT: A meta-predictor of intrinsically disordered amino acids, Biochim. Biophys. Acta - Proteins Proteomics. 1804 (2010) 996–1010. https://doi.org/10.1016/j.bbapap.2010.01.011.
[31] O.M. E, R. Pedro, I. Takashi, G. Mohamed, M.M. J, X. Bin, D. Zsuzsanna, U.V. N, O. Zoran, K. Lukasz, D.A. Keith, G. Julian, D2P2: Database of Disordered Protein Predictions, Nucleic Acids Res. (2013). https://pubmed.ncbi.nlm.nih.gov/23203878/ (accessed June 23, 2020).
[32] M. Gouw, H. Sámano-Sánchez, K. Van Roey, F. Diella, T.J. Gibson, H. Dinkel, Exploring short linear motifs using the ELM database and tools, Curr. Protoc. Bioinforma. 2017 (2017) 8.22.1-8.22.35. https://doi.org/10.1002/cpbi.26.
[33] D. Szklarczyk, A.L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas, M. Simonovic, N.T. Doncheva, J.H. Morris, P. Bork, L.J. Jensen, C. von Mering, C. Von Mering, STRING v11: Protein-Protein Association Networks With Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets, Nucleic Acids Res. 47 (2019) D607–D613. https://pubmed.ncbi.nlm.nih.gov/30476243/ (accessed June 23, 2020).
[34] E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, T.E. Ferrin, UCSF Chimera - A visualization system for exploratory research and analysis, J. Comput. Chem. 25 (2004) 1605–1612. https://doi.org/10.1002/jcc.20084.
[35] Y. Asaoka, H. Nishina, Diverse physiological functions of MKK4 and MKK7 during early embryogenesis, J. Biochem. 148 (2010) 393–401. https://doi.org/10.1093/jb/mvq098.
[36] T. Fujisawa, K. Takeda, H. Ichijo, ASK family proteins in stress response and disease, in: Mol. Biotechnol., Mol Biotechnol, 2007: pp. 13–18. https://doi.org/10.1007/s12033-007-0053-x.
[37] K. Takeda, R. Shimozono, T. Noguchi, T. Umeda, Y. Morimoto, I. Naguro, K. Tobiume, M. Saitoh, A. Matsuzawa, H. Ichijo, Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1, J. Biol. Chem. 282 (2007) 7522–7531. https://doi.org/10.1074/jbc.M607177200.
[38] M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, H. Ichijo, Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1, EMBO J. 17 (1998) 2596–2606. https://doi.org/10.1093/emboj/17.9.2596.
[39] H. Liu, H. Nishitoh, H. Ichijo, J.M. Kyriakis, Activation of Apoptosis Signal-Regulating Kinase 1 (ASK1) by Tumor Necrosis Factor Receptor-Associated Factor 2 Requires Prior Dissociation of the ASK1 Inhibitor Thioredoxin, Mol. Cell. Biol. 20 (2000) 2198–2208. https://doi.org/10.1128/mcb.20.6.2198-2208.2000.
[40] L.M. Cockrell, M.C. Puckett, E.H. Goldman, F.R. Khuri, H. Fu, Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome, Oncogene. 29 (2010) 822–830. https://doi.org/10.1038/onc.2009.382.
[41] T. Noguchi, K. Takeda, A. Matsuzawa, K. Saegusa, H. Nakano, J. Gohda, J.I. Inoue, H. Ichijo, Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death, J. Biol. Chem. 280 (2005) 37033–37040. https://doi.org/10.1074/jbc.M506771200.
[42] G. Fujino, T. Noguchi, A. Matsuzawa, S. Yamauchi, M. Saitoh, K. Takeda, H. Ichijo, Thioredoxin and TRAF Family Proteins Regulate Reactive Oxygen Species-Dependent Activation of ASK1 through Reciprocal Modulation of the N-Terminal Homophilic Interaction of ASK1, Mol. Cell. Biol. 27 (2007) 8152–8163. https://doi.org/10.1128/mcb.00227-07.
[43] C. Tournier, C. Dong, T.K. Turner, S.N. Jones, R.A. Flavell, R.J. Davis, MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines, Genes Dev. 15 (2001) 1419–1426. https://doi.org/10.1101/gad.888501.
[44] J. Liu, A. Lin, Role of JNK activation in apoptosis: A double-edged sword, Cell Res. 15 (2005) 36–42. https://doi.org/10.1038/sj.cr.7290262.
[45] A.J. Whitmarsh, J. Cavanagh, C. Tournier, J. Yasuda, R.J. Davis, A mammalian scaffold complex that selectively mediates MAP kinase activation, Science (80-. ). 281 (1998) 1671–1674. https://doi.org/10.1126/science.281.5383.1671.
[46] O. Bermudez, G. Pagès, C. Gimond, The dual-specificity MAP kinase phosphatases: Critical roles in development and cancer, Am. J. Physiol. - Cell Physiol. 299 (2010). https://doi.org/10.1152/ajpcell.00347.2009.
[47] Q. Meng, Y. Xia, c-Jun, at the crossroad of the signaling network, Protein Cell. 2 (2011) 889–898. https://doi.org/10.1007/s13238-011-1113-3.
[48] K. Rajagopalan, S.M. Mooney, N. Parekh, R.H. Getzenberg, P. Kulkarni, A majority of the cancer/testis antigens are intrinsically disordered proteins, J. Cell. Biochem. 112 (2011) 3256–3267. https://doi.org/10.1002/jcb.23252.
[49] K. Gadhave, B.R. Gehi, P. Kumar, B. Xue, V.N. Uversky, R. Giri, The dark side of Alzheimer’s disease: unstructured biology of proteins from the amyloid cascade signaling pathway, Cell. Mol. Life Sci. (2020). https://doi.org/10.1007/s00018-019-03414-9.
[50] Z. Dosztányi, B. Mészáros, I. Simon, ANCHOR: Web server for predicting protein binding regions in disordered proteins, Bioinformatics. 25 (2009) 2745–2746. https://doi.org/10.1093/bioinformatics/btp518.
[51] S. Shiizaki, I. Naguro, H. Ichijo, Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling, Adv. Biol. Regul. 53 (2013) 135–144. https://doi.org/10.1016/j.jbior.2012.09.006.
[52] G. Bunkoczi, E. Salah, P. Filippakopoulos, O. Fedorov, S. Müller, F. Sobott, S.A. Parker, H. Zhang, W. Min, B.E. Turk, S. Knapp, Structural and Functional Characterization of the Human Protein Kinase ASK1, Structure. 15 (2007) 1215–1226. https://doi.org/10.1016/j.str.2007.08.011.
[53] H. Ichijo, E. Nishida, K. Irie, P. Ten Dijke, M. Saitoh, T. Moriguchi, M. Takagi, K. Matsumoto, K. Miyazono, Y. Gotoh, Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways, Science (80-. ). 275 (1997) 90–94. https://doi.org/10.1126/science.275.5296.90.
[54] Y.R. Chen, X. Wang, D. Templeton, R.J. Davis, T.H. Tan, The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation, J. Biol. Chem. 271 (1996) 31929–31936. https://doi.org/10.1074/jbc.271.50.31929.
[55] P.H. McDonald, beta -Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3, Science (80-. ). 290 (2000) 1574–1577. https://doi.org/10.1126/science.290.5496.1574.
[56] Y. Liu, W. Min, Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner, Circ. Res. 90 (2002) 1259–1266. https://doi.org/10.1161/01.RES.0000022160.64355.62.
[57] K. Tobiume, M. Saitoh, H. Ichijo, Activation of apoptosis signal-regulating Kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer, J. Cell. Physiol. 191 (2002) 95–104. https://doi.org/10.1002/jcp.10080.
[58] Y. Hashimoto, T. Niikura, T. Chiba, E. Tsukamoto, H. Kadowaki, H. Nishitoh, Y. Yamagishi, M. Ishizaka, M. Yamada, M. Nawa, K. Terashita, S. Aiso, H. Ichijo, I. Nishimoto, The cytoplasmic domain of Alzheimer’s amyloid-β protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH 2-terminal kinase-mediated neurotoxic signal via dimerization, J. Pharmacol. Exp. Ther. 306 (2003) 889–902. https://doi.org/10.1124/jpet.103.051383.
[59] H. Kadowaki, H. Nishitoh, F. Urano, C. Sadamitsu, A. Matsuzawa, K. Takeda, H. Masutani, J. Yodoi, Y. Urano, T. Nagano, H. Ichijo, Amyloid β induces neuronal cell death through ROS-mediated ASK1 activation, Cell Death Differ. 12 (2005) 19–24. https://doi.org/10.1038/sj.cdd.4401528.
[60] J. Zhang, E.S. Park, H.J. Park, R. Yan, M. Grudniewska, X. Zhang, S. Oh, X. Yang, J. Baum, M.M. Mouradian, Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice, Neurobiol. Aging. 85 (2020) 49–57. https://doi.org/10.1016/j.neurobiolaging.2019.09.012.
[61] J.F. Weijman, A. Kumar, S.A. Jamieson, C.M. King, T.T. Caradoc-Davies, E.C. Ledgerwood, J.M. Murphy, P.D. Mace, Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1, Proc. Natl. Acad. Sci. U. S. A. 114 (2017) E2096–E2105. https://doi.org/10.1073/pnas.1620813114.
[62] O. Petrvalska, D. Kosek, Z. Kukacka, Z. Tosner, P. Man, J. Vecer, P. Herman, V. Obsilova, T. Obsil, Structural insight into the 14-3-3 protein-dependent inhibition of protein kinase ASK1 (apoptosis signal-regulating kinase 1), J. Biol. Chem. 291 (2016) 20753–20765. https://doi.org/10.1074/jbc.M116.724310.
[63] E. Ortner, K. Moelling, Heteromeric complex formation of ASK2 and ASK1 regulates stress-induced signaling, Biochem. Biophys. Res. Commun. 362 (2007) 454–459. https://doi.org/10.1016/j.bbrc.2007.08.006.
[64] T. Iriyama, K. Takeda, H. Nakamura, Y. Morimoto, T. Kuroiwa, J. Mizukami, T. Umeda, T. Noguchi, I. Naguro, H. Nishitoh, K. Saegusa, K. Tobiume, T. Homma, Y. Shimada, H. Tsuda, S. Aiko, I. Imoto, J. Inazawa, K. Chida, Y. Kamei, S. Kozuma, Y. Taketani, A. Matsuzawa, H. Ichijo, ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis, EMBO J. 28 (2009) 843–853. https://doi.org/10.1038/emboj.2009.32.
[65] K. Fritz-Wolf, S. Kehr, M. Stumpf, S. Rahlfs, K. Becker, Crystal structure of the human thioredoxin reductase-thioredoxin complex, Nat. Commun. 2 (2011). https://doi.org/10.1038/ncomms1382.
[66] G. Spyrou, E. Enmark, A. Miranda-Vizuete, J.Å. Gustafsson, Cloning and expression of a novel mammalian thioredoxin, J. Biol. Chem. 272 (1997) 2936–2941. https://doi.org/10.1074/jbc.272.5.2936.
[67] R. Zhang, R. Al-Lamki, L. Bai, J.W. Streb, J.M. Miano, J. Bradley, W. Min, Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner, Circ. Res. 94 (2004) 1483–1491. https://doi.org/10.1161/01.RES.0000130525.37646.a7.
[68] K.F. Tonissen, J.R.E. Wells, Isolation and characterization of human thioredoxin-encoding genes, Gene. 102 (1991) 221–228. https://doi.org/10.1016/0378-1119(91)90081-L.
[69] A. Holmgren, Thioredoxin, Annu. Rev. Biochem. 54 (1985) 237–271. https://doi.org/10.1146/annurev.bi.54.070185.001321.
[70] G. Powis, W.R. Montfort, Properties and biological activities of thioredoxins, Annu. Rev. Biophys. Biomol. Struct. 30 (2001) 421–455. https://doi.org/10.1146/annurev.biophys.30.1.421.
[71] H. Fu, R.R. Subramanian, S.C. Masters, 14-3-3 Proteins: Structure, Function, and Regulation, Annu. Rev. Pharmacol. Toxicol. 40 (2000) 617–647. https://doi.org/10.1146/annurev.pharmtox.40.1.617.
[72] K. Pennington, T. Chan, M. Torres, J. Andersen, The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein–protein interactions, Oncogene. 37 (2018) 5587–5604. https://doi.org/10.1038/s41388-018-0348-3.
[73] E.H. Goldman, L. Chen, H. Fu, Activation of Apoptosis Signal-regulating Kinase 1 by Reactive Oxygen Species through Dephosphorylation at Serine 967 and 14-3-3 Dissociation, J. Biol. Chem. 279 (2004) 10442–10449. https://doi.org/10.1074/jbc.M311129200.
[74] K. Kaneko, N.S. Hachiya, The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions, Med. Hypotheses. 67 (2006) 169–171. https://doi.org/10.1016/j.mehy.2006.01.019.
[75] Z.Y. Foote Molly, 14-3-3 proteins in neurological disorders, Int J Biochem Mol Biol . 3 (2012) 152–164. www.ijbmb.org (accessed June 23, 2020).
[76] K. Rittinger, J. Budman, J. Xu, S. Volinia, L.C. Cantley, S.J. Smerdon, S.J. Gamblin, M.B. Yaffe, Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding, Mol. Cell. 4 (1999) 153–166. https://doi.org/10.1016/S1097-2765(00)80363-9.
[77] P. Xie, TRAF molecules in cell signaling and in human diseases, J. Mol. Signal. 8 (2013). https://doi.org/10.1186/1750-2187-8-7.
[78] H.H. Park, Structure of TRAF Family: Current Understanding of Receptor Recognition, Front. Immunol. 9 (2018) 1999. https://doi.org/10.3389/fimmu.2018.01999.
[79] J.R. Bradley, J.S. Pober, Tumor necrosis factor receptor-associated factors (TRAFs), Oncogene. 20 (2001) 6482–6491. https://doi.org/10.1038/sj.onc.1204788.
[80] Q. Yin, B. Lamothe, B.G. Darnay, H. Wu, Structural basis for the lack of E2 interaction in the RING domain of TRAF2, Biochemistry. 48 (2009) 10558–10567. https://doi.org/10.1021/bi901462e.
[81] S.M. McWhirter, S.S. Pullen, J.M. Holton, J.J. Crute, M.R. Kehry, T. Alber, Crystallographic analysis of CD40 recognition and signaling by human TRAF2, Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8408–8413. https://doi.org/10.1073/pnas.96.15.8408.
[82] C. Zheng, V. Kabaleeswaran, Y. Wang, G. Cheng, H. Wu, Crystal Structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 Complexes: Affinity, Specificity, and Regulation, Mol. Cell. 38 (2010) 101–113. https://doi.org/10.1016/j.molcel.2010.03.009.
[83] Q. Yin, S.C. Lin, B. Lamothe, M. Lu, Y.C. Lo, G. Hura, L. Zheng, R.L. Rich, A.D. Campos, D.G. Myszka, M.J. Lenardo, B.G. Darnay, H. Wu, E2 interaction and dimerization in the crystal structure of TRAF6, Nat. Struct. Mol. Biol. 16 (2009) 658–666. https://doi.org/10.1038/nsmb.1605.
[84] K. Gadhave, P. Kumar, S.K. Kapuganti, V.N. Uversky, R. Giri, Unstructured Biology of Proteins from Ubiquitin-Proteasome System: Roles in Cancer and Neurodegenerative Diseases, Biomolecules. 10 (2020) 796. https://doi.org/10.3390/biom10050796.
[85] H. Ye, J.R. Arron, B. Lamothe, M. Cirilli, T. Kobayashi, N.K. Shevde, D. Segal, O.K. Dzivenu, M. Vologodskaia, M. Yim, K. Du, S. Singh, J.W. Pike, B.G. Darnay, Y. Choi, H. Wu, Distinct molecular mechanism for initiating TRAF6 signalling, Nature. 418 (2002) 443–447. https://doi.org/10.1038/nature00888.
[86] C. Widmann, S. Gibson, M.B. Jarpe, G.L. Johnson, Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human, Physiol. Rev. 79 (1999) 143–180. https://doi.org/10.1152/physrev.1999.79.1.143.
[87] X. Wang, A. Destrument, C. Tournier, Physiological roles of MKK4 and MKK7: Insights from animal models, Biochim. Biophys. Acta - Mol. Cell Res. 1773 (2007) 1349–1357. https://doi.org/10.1016/j.bbamcr.2006.10.016.
[88] J.G. Park, N. Aziz, J.Y. Cho, MKK7, the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target, Ther. Adv. Med. Oncol. 11 (2019). https://doi.org/10.1177/1758835919875574.
[89] T. Matsumoto, T. Kinoshita, Y. Kirii, K. Yokota, K. Hamada, T. Tada, Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition state, Biochem. Biophys. Res. Commun. 400 (2010) 369–373. https://doi.org/10.1016/j.bbrc.2010.08.071.
[90] Y. Sogabe, T. Hashimoto, T. Matsumoto, Y. Kirii, M. Sawa, T. Kinoshita, A crucial role of Cys218 in configuring an unprecedented auto-inhibition form of MAP2K7, Biochem. Biophys. Res. Commun. 473 (2016) 476–481. https://doi.org/10.1016/j.bbrc.2016.03.036.
[91] A. Estaña, N. Sibille, E. Delaforge, M. Vaisset, J. Cortés, P. Bernadó, Realistic Ensemble Models of Intrinsically Disordered Proteins Using a Structure-Encoding Coil Database, Structure. 27 (2019) 381-391.e2. https://doi.org/10.1016/j.str.2018.10.016.
[92] L. Resnick, M. Fennell, Targeting JNK3 for the treatment of neurodegenerative disorders, Drug Discov. Today. 9 (2004) 932–939. https://doi.org/10.1016/S1359-6446(04)03251-9.
[93] M. Raciti, L. V. Lotti, S. Valia, F.M. Pulcinelli, L. Di Renzo, JNK2 is activated during ER stress and promotes cell survival, Cell Death Dis. 3 (2012). https://doi.org/10.1038/cddis.2012.167.
[94] V. Aguirre, T. Uchida, L. Yenush, R. Davis, M.F. White, The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307, J. Biol. Chem. 275 (2000) 9047–9054. https://doi.org/10.1074/jbc.275.12.9047.
[95] A. Jaeschke, M.P. Czech, R.J. Davis, An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue, Genes Dev. 18 (2004) 1976–1980. https://doi.org/10.1101/gad.1216504.
[96] A. Jaeschke, M. Rincón, B. Doran, J. Reilly, D. Neuberg, D.L. Greiner, L.D. Shultz, A.A. Rossini, R.A. Flavell, R.J. Davis, Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type 1 diabetes, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6931–6935. https://doi.org/10.1073/pnas.0502143102.
[97] H. Kaneto, Y. Nakatani, T. Miyatsuka, D. Kawamori, T.A. Matsuoka, M. Matsuhisa, Y. Kajimoto, H. Ichijo, Y. Yamasaki, M. Hori, Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide, Nat. Med. 10 (2004) 1128–1132. https://doi.org/10.1038/nm1111.
[98] Á. Garai, A. Zeke, G. Gógl, I. Töro, F. Fördos, H. Blankenburg, T. Bárkai, J. Varga, A. Alexa, D. Emig, M. Albrecht, A. Reményi, Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove, Sci. Signal. 5 (2012). https://doi.org/10.1126/scisignal.2003004.
[99] D. Shaw, S.M. Wang, A.G. Villaseñor, S. Tsing, D. Walter, M.F. Browner, J. Barnett, A. Kuglstatter, The Crystal Structure of JNK2 Reveals Conformational Flexibility in the MAP Kinase Insert and Indicates Its Involvement in the Regulation of Catalytic Activity, J. Mol. Biol. 383 (2008) 885–893. https://doi.org/10.1016/j.jmb.2008.08.086.
[100] V.P. Krenitsky, M. Delgado, L. Nadolny, K. Sahasrabudhe, L. Ayala, S.S. Clareen, R. Hilgraf, R. Albers, A. Kois, K. Hughes, J. Wright, J. Nowakowski, E. Sudbeck, S. Ghosh, S. Bahmanyar, P. Chamberlain, J. Muir, B.E. Cathers, D. Giegel, L. Xu, M. Celeridad, M. Moghaddam, O. Khatsenko, P. Omholt, J. Katz, S. Pai, R. Fan, Y. Tang, M.A. Shirley, B. Benish, K. Blease, H. Raymon, S. Bhagwat, I. Henderson, A.G. Cole, B. Bennett, Y. Satoh, Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury, Bioorganic Med. Chem. Lett. 22 (2012) 1427–1432. https://doi.org/10.1016/j.bmcl.2011.12.028.
[101] J.D. Laughlin, J.C. Nwachukwu, M. Figuera-Losada, L. Cherry, K.W. Nettles, P. V. Lograsso, Structural mechanisms of allostery and autoinhibition in JNK family kinases, Structure. 20 (2012) 2174–2184. https://doi.org/10.1016/j.str.2012.09.021.
[102] S. Pernigo, M.S. Chegkazi, Y.Y. Yip, C. Treacy, G. Glorani, K. Hansen, A. Politis, S. Bui, M.P. Dodding, R.A. Steiner, Structural basis for isoform-specific kinesin-1 recognition of Y-acidic cargo adaptors, Elife. 7 (2018). https://doi.org/10.7554/eLife.38362.
[103] A.J. Whitmarsh, C.Y. Kuan, N.J. Kennedy, N. Kelkar, T.F. Haydar, J.P. Mordes, M. Appel, A.A. Rossini, S.N. Jones, R.A. Flavell, P. Rakic, R.J. Davis, Requirement of the JIP1 scaffold protein for stress-induced JNK activation, Genes Dev. 15 (2001) 2421–2432. https://doi.org/10.1101/gad.922801.
[104] D. Meyer, A. Liu, B. Margolis, Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons, J. Biol. Chem. 274 (1999) 35113–35118. https://doi.org/10.1074/jbc.274.49.35113.
[105] W. Stockinger, C. Brandes, D. Fasching, M. Hermann, M. Gotthardt, J. Herz, W.J. Schneider, J. Nimpf, The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2, J. Biol. Chem. 275 (2000) 25625–25632. https://doi.org/10.1074/jbc.M004119200.
[106] M. Gotthardt, M. Trommsdorff, M.F. Nevitt, J. Shelton, J.A. Richardson, W. Stockinger, J. Nimpf, J. Herz, Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction, J. Biol. Chem. 275 (2000) 25616–25624. https://doi.org/10.1074/jbc.M000955200.
[107] K.J. Verhey, D. Meyer, R. Deehan, J. Blenis, B.J. Schnapp, T.A. Rapoport, B. Margolis, Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules, J. Cell Biol. 152 (2001) 959–970. https://doi.org/10.1083/jcb.152.5.959.
[108] M.M. Fu, E.L.F. Holzbaur, JIP1 regulates the directionality of APP axonal transport by coordinating kinesin and dynein motors, J. Cell Biol. 202 (2013) 495–508. https://doi.org/10.1083/jcb.201302078.
[109] A.J. Whitmarsh, The JIP family of MAPK scaffold proteins, Biochem. Soc. Trans. 34 (2006) 828–832. https://doi.org/10.1042/BST0340828.
[110] H. Taru, K.I. Iijima, M. Hase, Y. Kirino, Y. Yagi, T. Suzuki, Interaction of Alzheimer’s β-amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade, J. Biol. Chem. 277 (2002) 20070–20078. https://doi.org/10.1074/jbc.M108372200.
[111] N. Kelkar, S. Gupta, M. Dickens, R.J. Davis, Interaction of a Mitogen-Activated Protein Kinase Signaling Module with the Neuronal Protein JIP3, Mol. Cell. Biol. 20 (2000) 1030–1043. https://doi.org/10.1128/mcb.20.3.1030-1043.2000.
[112] T. Sun, N. Yu, L.K. Zhai, N. Li, C. Zhang, L. Zhou, Z. Huang, X.Y. Jiang, Y. Shen, Z.Y. Chen, C-Jun NH2-terminal kinase (JNK)-interacting protein-3 (JIP3) regulates neuronal axon elongation in a kinesin- And JNK-dependent manner, J. Biol. Chem. 288 (2013) 14531–14543. https://doi.org/10.1074/jbc.M113.464453.
[113] P. Llinas, M. Chenon, T.Q. Nguyen, C. Moreira, A. De Régibus, A. Coquard, M.J. Ramos, R. Guérois, P.A. Fernandes, J. Ménétrey, Structure of a truncated form of leucine zipper II of JIP3 reveals an unexpected antiparallel coiled-coil arrangement, Acta Crystallogr. Sect. Struct. Biol. Commun. 72 (2016) 198–206. https://doi.org/10.1107/S2053230X16001576.
[114] D.M. Owens, S.M. Keyse, Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases, Oncogene. 26 (2007) 3203–3213. https://doi.org/10.1038/sj.onc.1210412.
[115] K.I. Patterson, T. Brummer, P.M. O’Brien, R.J. Daly, Dual-specificity phosphatases: Critical regulators with diverse cellular targets, Biochem. J. 418 (2009) 475–489. https://doi.org/10.1042/BJ20082234.
[116] X. Liu, C.S. Zhang, C. Lu, S.C. Lin, J.W. Wu, Z.X. Wang, A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation, Nat. Commun. 7 (2016). https://doi.org/10.1038/ncomms10879.
[117] Y. Son, Y.-K. Cheong, N.-H. Kim, H.-T. Chung, D.G. Kang, H.-O. Pae, Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?, J. Signal Transduct. 2011 (2011). https://doi.org/10.1155/2011/792639.
[118] C.H. Teng, W.N. Huang, T.C. Meng, Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress, J. Biol. Chem. 282 (2007) 28395–28407. https://doi.org/10.1074/jbc.M705142200.
[119] J.Y. Zhou, Y. Liu, S.W. Gen, The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death, Cancer Res. 66 (2006) 4888–4894. https://doi.org/10.1158/0008-5472.CAN-05-4229.
[120] R. Gumpena, G.T. Lountos, D.S. Waugh, MBP-binding DARPins facilitate the crystallization of an MBP fusion protein, Acta Crystallogr. Sect. F Struct. Biol. Commun. 74 (2018) 549–557. https://doi.org/10.1107/S2053230X18009901.
[121] X. Tao, L. Tong, Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5, Protein Sci. 16 (2007) 880–886. https://doi.org/10.1110/ps.062712807.
[122] P. Angel, M. Karin, The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation, Biochim. Biophys. Acta - Rev. Cancer. 1072 (1991) 129–157. https://doi.org/10.1016/0304-419X(91)90011-9.
[123] T. Hai, F. Liu, E.A. Allegretto, M. Karin, M.R. Green, A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1, Genes Dev. 2 (1988) 1216–1226. https://doi.org/10.1101/GAD.2.10.1216.